About this trial
Pudendal neuralgia (PN) is a chronic nerve compression syndrome causing neuropathic pain. Treatment includes medication, infiltration and decompressive surgery. Medicinal treatment involves the use of drugs that have proved effective in other areas, such as shingles or diabetes. There is no consensus on the molecules to be used for pudendal nerve infiltration (PNTI), and less than half of patients experience short-term relief. The only risk factor for failure is the duration of pain. Our study proposes to compare the usual treatment with a placebo, as no type of infiltration has been compared with a placebo.
Eligibility criteria
Qualifiers
Patient 18 years of age or older,
Expressed consent to participate in the study
Affiliated or beneficiary of a social security plan
With pudendal neuralgia (Nantes criteria "modified" Nantes criteria).
Disqualifiers
Patient benefiting from a legal protection measure
Pregnant or breastfeeding woman
General and/or local infection (fistulous or cutaneous suppuration of the anal margin) in progress
Known neurological pathology that may explain the pain
Trial design
Treatments tested in this trial
- Lidocaine Injectable Solution
- Saline Solution for Block